Status:
COMPLETED
A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research
Lead Sponsor:
UnitedHealth Group
Collaborating Sponsors:
PATH
Mayo Clinic
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
Brief Summary
Minimal risk research study: 1. Comparing polyester nasal swabs and foam nasal swabs to detect SARS-CoV-2 virus; 2. Quantifying the development and trajectory of the disease through clinic visits and...
Detailed Description
This work will serve both the Everett Clinic and broader UnitedHealth Group patient populations as well as advance the public health emergency response to the community spread of SARS-CoV-2 virus, esp...
Eligibility Criteria
Inclusion
- Existing patient of the Everett Clinic (i.e., has previously sought care)
- Tested positive for SARS-CoV-2 virus (confirmed by RT-PCR) prior to time of enrollment
Exclusion
- Not able to demonstrate understanding of the study
- Not able to safely travel to the clinic without endangering themselves or risking exposing others to SARS-CoV-2
- Medical history evidencing any of the following
- Active nosebleed in the past 24 hours
- Nasal surgery in the past two weeks
- Chemotherapy treatment with low platelet and low white blood cell counts
- Acute facial trauma
- Advanced COVID-19 state that would preclude safe and feasible sample collection
Key Trial Info
Start Date :
March 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2020
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT04327804
Start Date
March 25 2020
End Date
October 10 2020
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Everett Clinic
Seattle, Washington, United States, 98133